Search Results - "Double-Blind Method [MeSH]"
-
1
Authors: et al.
Source: Medicine & Science in Sports & Exercise. 57(11)
Subject Terms: 3208 Medical Physiology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Women's Health (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Myofibrils (mesh), Muscle, Skeletal (mesh), Humans (mesh), Collagen (mesh), Amino Acids (mesh), Phenylalanine (mesh), Muscle Proteins (mesh), Double-Blind Method (mesh), Protein Biosynthesis (mesh), Adult (mesh), Female (mesh), Male (mesh), Resistance Training (mesh), Young Adult (mesh), CONNECTIVE TISSUE, GLYCINE, MYOFIBRILLAR PROTEINS, RESISTANCE EXERCISE, Humans (mesh), Male (mesh), Double-Blind Method (mesh), Female (mesh), Muscle Proteins (mesh), Young Adult (mesh), Collagen (mesh), Amino Acids (mesh), Muscle, Skeletal (mesh), Myofibrils (mesh), Adult (mesh), Phenylalanine (mesh), Resistance Training (mesh), Protein Biosynthesis (mesh), 1106 Human Movement and Sports Sciences (for), 1116 Medical Physiology (for), 1117 Public Health and Health Services (for), Sport Sciences (science-metrix), 3202 Clinical sciences (for-2020), 3208 Medical physiology (for-2020), 4207 Sports science and exercise (for-2020)
File Description: application/pdf
-
2
Authors: et al.
Source: Otolaryngology. 172(4)
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Clinical Research (rcdc), Brain Disorders (rcdc), Women's Health (rcdc), Clinical Trials and Supportive Activities (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Humans (mesh), Tinnitus (mesh), Nortriptyline (mesh), Male (mesh), Female (mesh), Double-Blind Method (mesh), Middle Aged (mesh), Verapamil (mesh), Adult (mesh), Treatment Outcome (mesh), Drug Combinations (mesh), Drug Therapy, Combination (mesh), Aged (mesh), Severity of Illness Index (mesh), migraine, nortriptyline-topiramate, randomized clinical trial, tinnitus, verapamil-paroxetine, Humans (mesh), Tinnitus (mesh), Verapamil (mesh), Nortriptyline (mesh), Drug Combinations (mesh), Treatment Outcome (mesh), Drug Therapy, Combination (mesh), Severity of Illness Index (mesh), Double-Blind Method (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), migraine, nortriptyline‐topiramate, randomized clinical trial, tinnitus, verapamil‐paroxetine, Humans (mesh), Tinnitus (mesh), Nortriptyline (mesh), Male (mesh), Female (mesh), Double-Blind Method (mesh), Middle Aged (mesh), Verapamil (mesh), Adult (mesh), Treatment Outcome (mesh), Drug Combinations (mesh), Drug Therapy, Combination (mesh), Aged (mesh), Severity of Illness Index (mesh), 1103 Clinical Sciences (for), Otorhinolaryngology (science-metrix), 3202 Clinical sciences (for-2020)
File Description: application/pdf
-
3
Authors: et al.
Source: European Journal of Cancer. 218
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Genetic Testing (rcdc), Rare Diseases (rcdc), Human Genome (rcdc), Clinical Research (rcdc), Cancer (rcdc), Pediatric Cancer (rcdc), Neurosciences (rcdc), Precision Medicine (rcdc), Cancer Genomics (rcdc), Prevention (rcdc), Pediatric (rcdc), Genetics (rcdc), Neuroblastoma (rcdc), Minority Health (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), Humans (mesh), Neuroblastoma (mesh), Retrospective Studies (mesh), Female (mesh), Male (mesh), Prognosis (mesh), Prospective Studies (mesh), Biomarkers, Tumor (mesh), Child, Preschool (mesh), Double-Blind Method (mesh), Infant (mesh), Child (mesh), Treatment Outcome (mesh), Large Language Models (mesh), Neuroblastoma, Cellular morphometric biomarker, Large language model, Prognosis, Treatment response, Retrospective study, Prospective study, Humans (mesh), Neuroblastoma (mesh), Prognosis (mesh), Treatment Outcome (mesh), Retrospective Studies (mesh), Prospective Studies (mesh), Double-Blind Method (mesh), Child (mesh), Child, Preschool (mesh), Infant (mesh), Female (mesh), Male (mesh), Biomarkers, Tumor (mesh), Large Language Models (mesh), Cellular morphometric biomarker, Large language model, Neuroblastoma, Prognosis, Prospective study, Retrospective study, Treatment response, Humans (mesh), Neuroblastoma (mesh), Retrospective Studies (mesh), Female (mesh), Male (mesh), Prognosis (mesh), Prospective Studies (mesh), Biomarkers, Tumor (mesh), Child, Preschool (mesh), Double-Blind Method (mesh), Infant (mesh), Child (mesh), Treatment Outcome (mesh), Large Language Models (mesh), 1112 Oncology and Carcinogenesis (for), 1117 Public Health and Health Services (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)
Access URL: https://escholarship.org/uc/item/4102j46z
-
4
Authors: et al.
Source: PLOS Medicine. 22(9)
Subject Terms: 3207 Medical Microbiology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Prevention (rcdc), Comparative Effectiveness Research (rcdc), Infant Mortality (rcdc), Perinatal Period - Conditions Originating in Perinatal Period (rcdc), Clinical Research (rcdc), Women's Health (rcdc), Rare Diseases (rcdc), Preterm, Low Birth Weight and Health of the Newborn (rcdc), Infectious Diseases (rcdc), Antimicrobial Resistance (rcdc), Maternal Health (rcdc), Clinical Trials and Supportive Activities (rcdc), Vector-Borne Diseases (rcdc), Conditions Affecting the Embryonic and Fetal Periods (rcdc), Malaria (rcdc), Pediatric (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Reproductive health and childbirth (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Female (mesh), Pregnancy (mesh), Pyrimethamine (mesh), Sulfadoxine (mesh), Quinolines (mesh), Artemisinins (mesh), Drug Combinations (mesh), Double-Blind Method (mesh), Antimalarials (mesh), Uganda (mesh), Adult (mesh), Pregnancy Complications, Parasitic (mesh), Drug Therapy, Combination (mesh), Young Adult (mesh), Adolescent (mesh), Infant, Newborn (mesh), Malaria, Falciparum (mesh), Malaria (mesh), Pregnancy Outcome (mesh), Piperazines (mesh), Humans (mesh), Pregnancy Complications, Parasitic (mesh), Malaria (mesh), Malaria, Falciparum (mesh), Sulfadoxine (mesh), Artemisinins (mesh), Piperazines (mesh), Pyrimethamine (mesh), Quinolines (mesh), Drug Combinations (mesh), Antimalarials (mesh), Pregnancy Outcome (mesh), Drug Therapy, Combination (mesh), Double-Blind Method (mesh), Pregnancy (mesh), Adolescent (mesh), Adult (mesh), Infant, Newborn (mesh), Uganda (mesh), Female (mesh), Young Adult (mesh), Humans (mesh), Female (mesh), Pregnancy (mesh), Pyrimethamine (mesh), Sulfadoxine (mesh), Quinolines (mesh), Artemisinins (mesh), Drug Combinations (mesh), Double-Blind Method (mesh), Antimalarials (mesh), Uganda (mesh), Adult (mesh), Pregnancy Complications, Parasitic (mesh), Drug Therapy, Combination (mesh), Young Adult (mesh), Adolescent (mesh), Infant, Newborn (mesh), Malaria, Falciparum (mesh), Malaria (mesh), Pregnancy Outcome (mesh), Piperazines (mesh), 11 Medical and Health Sciences (for), General & Internal Medicine (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)
File Description: application/pdf
-
5
Authors: et al.
Source: Diabetes Care. 48(1)
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Autoimmune Disease (rcdc), Clinical Trials and Supportive Activities (rcdc), Diabetes (rcdc), Clinical Research (rcdc), 6.1 Pharmaceuticals (hrcs-rac), 5.1 Pharmaceuticals (hrcs-rac), Metabolic and endocrine (hrcs-hc), Humans (mesh), Diabetes Mellitus, Type 1 (mesh), Sodium-Glucose Transporter 2 Inhibitors (mesh), Male (mesh), Female (mesh), Adult (mesh), Blood Glucose (mesh), Hypoglycemic Agents (mesh), Middle Aged (mesh), Double-Blind Method (mesh), Cross-Over Studies (mesh), Insulin (mesh), Receptors, Glucagon (mesh), Benzhydryl Compounds (mesh), Glucosides (mesh), Drug Therapy, Combination (mesh), Humans (mesh), Diabetes Mellitus, Type 1 (mesh), Benzhydryl Compounds (mesh), Insulin (mesh), Glucosides (mesh), Blood Glucose (mesh), Receptors, Glucagon (mesh), Hypoglycemic Agents (mesh), Drug Therapy, Combination (mesh), Cross-Over Studies (mesh), Double-Blind Method (mesh), Adult (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Sodium-Glucose Transporter 2 Inhibitors (mesh), Humans (mesh), Diabetes Mellitus, Type 1 (mesh), Sodium-Glucose Transporter 2 Inhibitors (mesh), Male (mesh), Female (mesh), Adult (mesh), Blood Glucose (mesh), Hypoglycemic Agents (mesh), Middle Aged (mesh), Double-Blind Method (mesh), Cross-Over Studies (mesh), Insulin (mesh), Receptors, Glucagon (mesh), Benzhydryl Compounds (mesh), Glucosides (mesh), Drug Therapy, Combination (mesh), 11 Medical and Health Sciences (for), Endocrinology & Metabolism (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)
File Description: application/pdf
-
6
Authors: et al.
Source: Tremor and Other Hyperkinetic Movements. 15(1)
Subject Terms: 5202 Biological Psychology (for-2020), 3214 Pharmacology and Pharmaceutical Sciences (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 52 Psychology (for-2020), Therapeutic Cannabinoid Research (rcdc), Cannabidiol Research (rcdc), Complementary and Integrative Health (rcdc), Cannabinoid Research (rcdc), Clinical Trials and Supportive Activities (rcdc), Clinical Research (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Humans (mesh), Cannabidiol (mesh), Dronabinol (mesh), Double-Blind Method (mesh), Female (mesh), Male (mesh), Cross-Over Studies (mesh), Essential Tremor (mesh), Middle Aged (mesh), Aged (mesh), Pilot Projects (mesh), Administration, Oral (mesh), Treatment Outcome (mesh), Adult (mesh), essential tremor, cannabis, therapeutics, digital outcome measures, Humans (mesh), Essential Tremor (mesh), Cannabidiol (mesh), Treatment Outcome (mesh), Administration, Oral (mesh), Pilot Projects (mesh), Cross-Over Studies (mesh), Double-Blind Method (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Dronabinol (mesh), cannabis, therapeutics, digital outcome measures, essential tremor, Humans (mesh), Cannabidiol (mesh), Dronabinol (mesh), Double-Blind Method (mesh), Female (mesh), Male (mesh), Cross-Over Studies (mesh), Essential Tremor (mesh), Middle Aged (mesh), Aged (mesh), Pilot Projects (mesh), Administration, Oral (mesh), Treatment Outcome (mesh), Adult (mesh)
File Description: application/pdf
-
7
Authors: et al.
Source: New England Journal of Medicine. 391(13)
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3201 Cardiovascular Medicine and Haematology (for-2020), 3202 Clinical Sciences (for-2020), Clinical Trials and Supportive Activities (rcdc), Clinical Research (rcdc), Lung (rcdc), Women's Health (rcdc), Obesity (rcdc), Sleep Research (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Cardiovascular (hrcs-hc), Adult (mesh), Female (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Blood Pressure (mesh), Body Weight (mesh), C-Reactive Protein (mesh), Double-Blind Method (mesh), Hypoxia (mesh), Obesity (mesh), Sleep Apnea, Obstructive (mesh), Severity of Illness Index (mesh), Gastric Inhibitory Polypeptide (mesh), Glucagon-Like Peptide-1 Receptor Agonists (mesh), Maximum Tolerated Dose (mesh), Sleep Quality (mesh), Treatment Outcome (mesh), Tirzepatide (mesh), SURMOUNT-OSA Investigators, Humans (mesh), Sleep Apnea, Obstructive (mesh), Obesity (mesh), Body Weight (mesh), Gastric Inhibitory Polypeptide (mesh), C-Reactive Protein (mesh), Treatment Outcome (mesh), Severity of Illness Index (mesh), Double-Blind Method (mesh), Maximum Tolerated Dose (mesh), Blood Pressure (mesh), Adult (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Hypoxia (mesh), Sleep Quality (mesh), Glucagon-Like Peptide-1 Receptor Agonists (mesh), Tirzepatide (mesh), Adult (mesh), Female (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Blood Pressure (mesh), Body Weight (mesh), C-Reactive Protein (mesh), Double-Blind Method (mesh), Hypoxia (mesh), Obesity (mesh), Sleep Apnea, Obstructive (mesh), Severity of Illness Index (mesh), Gastric Inhibitory Polypeptide (mesh), Glucagon-Like Peptide-1 Receptor Agonists (mesh), Maximum Tolerated Dose (mesh), Sleep Quality (mesh), Treatment Outcome (mesh), Tirzepatide (mesh), 11 Medical and Health Sciences (for), General & Internal Medicine (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)
File Description: application/pdf
-
8
Authors: et al.
Source: The Journal of Infectious Diseases. 230(2)
Subject Terms: 3207 Medical Microbiology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3204 Immunology (for-2020), Clinical Research (rcdc), Vaccine Related (AIDS) (rcdc), Sexually Transmitted Infections (rcdc), Immunization (rcdc), Infectious Diseases (rcdc), Clinical Trials and Supportive Activities (rcdc), Biotechnology (rcdc), Prevention (rcdc), Vaccine Related (rcdc), HIV/AIDS (rcdc), 6.1 Pharmaceuticals (hrcs-rac), 3.4 Vaccines (hrcs-rac), Infection (hrcs-hc), 3 Good Health and Well Being (sdg), Adolescent (mesh), Adult (mesh), Female (mesh), Humans (mesh), Male (mesh), Young Adult (mesh), Adjuvants, Immunologic (mesh), AIDS Vaccines (mesh), Double-Blind Method (mesh), HIV Antibodies (mesh), HIV Envelope Protein gp120 (mesh), HIV Infections (mesh), HIV-1 (mesh), Polysorbates (mesh), Squalene (mesh), Viral Vaccines (mesh), Off-Label Use (mesh), Vaccines, Combined (mesh), HIV, vaccine, dose, adjuvant, Humans (mesh), HIV-1 (mesh), HIV Infections (mesh), Polysorbates (mesh), Squalene (mesh), HIV Envelope Protein gp120 (mesh), Vaccines, Combined (mesh), Viral Vaccines (mesh), AIDS Vaccines (mesh), Adjuvants, Immunologic (mesh), HIV Antibodies (mesh), Double-Blind Method (mesh), Adolescent (mesh), Adult (mesh), Female (mesh), Male (mesh), Young Adult (mesh), Off-Label Use (mesh), HIV, adjuvant, dose, vaccine, Adolescent (mesh), Adult (mesh), Female (mesh), Humans (mesh), Male (mesh), Young Adult (mesh), Adjuvants, Immunologic (mesh), AIDS Vaccines (mesh), Double-Blind Method (mesh), HIV Antibodies (mesh), HIV Envelope Protein gp120 (mesh), HIV Infections (mesh), HIV-1 (mesh), Polysorbates (mesh), Squalene (mesh), Viral Vaccines (mesh), Off-Label Use (mesh), Vaccines, Combined (mesh), 06 Biological Sciences (for), 11 Medical and Health Sciences (for), Microbiology (science-metrix), 31 Biological sciences (for-2020), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)
File Description: application/pdf
-
9
Authors: et al.
Source: Journal of Lipid Research. 65(8)
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3210 Nutrition and Dietetics (for-2020), Obesity (rcdc), Prevention (rcdc), Nutrition (rcdc), Cardiovascular (rcdc), Clinical Research (rcdc), Cardiovascular (hrcs-hc), Stroke (hrcs-hc), Metabolic and endocrine (hrcs-hc), Humans (mesh), Female (mesh), Male (mesh), Middle Aged (mesh), Obesity (mesh), Overweight (mesh), Lipoprotein(a) (mesh), Adult (mesh), Sugar-Sweetened Beverages (mesh), Diet (mesh), Double-Blind Method (mesh), Fructose (mesh), glucose, fructose, nutrition, Lp(a) metabolism, apolipoprotein, Humans (mesh), Obesity (mesh), Fructose (mesh), Lipoprotein(a) (mesh), Diet (mesh), Double-Blind Method (mesh), Adult (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Overweight (mesh), Sugar-Sweetened Beverages (mesh), Lp(a) metabolism, apolipoprotein, fructose, glucose, nutrition, Humans (mesh), Female (mesh), Male (mesh), Middle Aged (mesh), Obesity (mesh), Overweight (mesh), Lipoprotein(a) (mesh), Adult (mesh), Sugar-Sweetened Beverages (mesh), Diet (mesh), Double-Blind Method (mesh), Fructose (mesh), 0601 Biochemistry and Cell Biology (for), 1101 Medical Biochemistry and Metabolomics (for), Biochemistry & Molecular Biology (science-metrix), 3101 Biochemistry and cell biology (for-2020), 3205 Medical biochemistry and metabolomics (for-2020)
File Description: application/pdf
-
10
Authors: et al.
Source: Ophthalmology. 131(8)
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3212 Ophthalmology and Optometry (for-2020), Neurodegenerative (rcdc), Eye Disease and Disorders of Vision (rcdc), Clinical Trials and Supportive Activities (rcdc), Patient Safety (rcdc), Clinical Research (rcdc), Macular Degeneration (rcdc), Neurosciences (rcdc), Aging (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Eye (hrcs-hc), Humans (mesh), Male (mesh), Female (mesh), Visual Acuity (mesh), Intravitreal Injections (mesh), Double-Blind Method (mesh), Antibodies, Bispecific (mesh), Aged (mesh), Angiogenesis Inhibitors (mesh), Vascular Endothelial Growth Factor A (mesh), Middle Aged (mesh), Recombinant Fusion Proteins (mesh), Wet Macular Degeneration (mesh), Receptors, Vascular Endothelial Growth Factor (mesh), Angiopoietin-2 (mesh), Treatment Outcome (mesh), Tomography, Optical Coherence (mesh), Follow-Up Studies (mesh), Aged, 80 and over (mesh), Fluorescein Angiography (mesh), Dose-Response Relationship, Drug (mesh), TENAYA and LUCERNE Investigators, Humans (mesh), Receptors, Vascular Endothelial Growth Factor (mesh), Angiogenesis Inhibitors (mesh), Angiopoietin-2 (mesh), Vascular Endothelial Growth Factor A (mesh), Recombinant Fusion Proteins (mesh), Antibodies, Bispecific (mesh), Tomography, Optical Coherence (mesh), Fluorescein Angiography (mesh), Treatment Outcome (mesh), Follow-Up Studies (mesh), Double-Blind Method (mesh), Visual Acuity (mesh), Dose-Response Relationship, Drug (mesh), Aged (mesh), Aged, 80 and over (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Wet Macular Degeneration (mesh), Intravitreal Injections (mesh), Angiopoietin-2, Faricimab, Neovascular age-related macular degeneration, Vascular endothelial growth factor A, Vascular stability, Humans (mesh), Male (mesh), Female (mesh), Visual Acuity (mesh), Intravitreal Injections (mesh), Double-Blind Method (mesh), Antibodies, Bispecific (mesh), Aged (mesh), Angiogenesis Inhibitors (mesh), Vascular Endothelial Growth Factor A (mesh), Middle Aged (mesh), Recombinant Fusion Proteins (mesh), Wet Macular Degeneration (mesh), Receptors, Vascular Endothelial Growth Factor (mesh), Angiopoietin-2 (mesh), Treatment Outcome (mesh), Tomography, Optical Coherence (mesh), Follow-Up Studies (mesh), Aged, 80 and over (mesh), Fluorescein Angiography (mesh), Dose-Response Relationship, Drug (mesh), 1103 Clinical Sciences (for), 1113 Opthalmology and Optometry (for), 1117 Public Health and Health Services (for), Ophthalmology & Optometry (science-metrix), 3212 Ophthalmology and optometry (for-2020)
File Description: application/pdf
-
11
Authors: et al.
Source: Contemporary Clinical Trials. 141
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3201 Cardiovascular Medicine and Haematology (for-2020), 3202 Clinical Sciences (for-2020), Obesity (rcdc), Women's Health (rcdc), Lung (rcdc), Clinical Trials and Supportive Activities (rcdc), Nutrition (rcdc), Clinical Research (rcdc), Sleep Research (rcdc), Prevention (rcdc), Behavioral and Social Science (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Metabolic and endocrine (hrcs-hc), Cancer (hrcs-hc), Cardiovascular (hrcs-hc), Oral and gastrointestinal (hrcs-hc), 3 Good Health and Well Being (sdg), Adult (mesh), Female (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Body Mass Index (mesh), Continuous Positive Airway Pressure (mesh), Double-Blind Method (mesh), Obesity (mesh), Polysomnography (mesh), Research Design (mesh), Severity of Illness Index (mesh), Sleep Apnea, Obstructive (mesh), Weight Loss (mesh), Sleep, Obesity, Apnea, Lung, Weight loss, Daily functioning, Humans (mesh), Sleep Apnea, Obstructive (mesh), Obesity (mesh), Weight Loss (mesh), Polysomnography (mesh), Body Mass Index (mesh), Continuous Positive Airway Pressure (mesh), Severity of Illness Index (mesh), Double-Blind Method (mesh), Research Design (mesh), Adult (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Apnea, Daily functioning, Lung, Obesity, Sleep, Weight loss, Adult (mesh), Female (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Body Mass Index (mesh), Continuous Positive Airway Pressure (mesh), Double-Blind Method (mesh), Obesity (mesh), Polysomnography (mesh), Research Design (mesh), Severity of Illness Index (mesh), Sleep Apnea, Obstructive (mesh), Weight Loss (mesh), 11 Medical and Health Sciences (for), General Clinical Medicine (science-metrix), Public Health (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)
File Description: application/pdf
-
12
Authors: et al.
Source: Environmental Health Perspectives. 132(6)
Subject Terms: 3215 Reproductive Medicine (for-2020), 32 Biomedical and Clinical Sciences (for-2020), Pediatric (rcdc), Tobacco Smoke and Health (rcdc), Perinatal Period - Conditions Originating in Perinatal Period (rcdc), Conditions Affecting the Embryonic and Fetal Periods (rcdc), Clinical Research (rcdc), Prevention (rcdc), Tobacco (rcdc), Reproductive health and childbirth (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Female (mesh), Pregnancy (mesh), DNA Methylation (mesh), Placenta (mesh), Biomarkers (mesh), Adult (mesh), Double-Blind Method (mesh), Machine Learning (mesh), program collaborators for Environmental influences on Child Health Outcomes, Placenta (mesh), Humans (mesh), Double-Blind Method (mesh), DNA Methylation (mesh), Pregnancy (mesh), Adult (mesh), Female (mesh), Biomarkers (mesh), Machine Learning (mesh), Humans (mesh), Female (mesh), Pregnancy (mesh), DNA Methylation (mesh), Placenta (mesh), Biomarkers (mesh), Adult (mesh), Double-Blind Method (mesh), Machine Learning (mesh), 05 Environmental Sciences (for), 11 Medical and Health Sciences (for), Toxicology (science-metrix), 32 Biomedical and clinical sciences (for-2020), 41 Environmental sciences (for-2020), 42 Health sciences (for-2020)
File Description: application/pdf
-
13
Authors: et al.
Source: Annals of Medicine, vol 57, iss 1
Subject Terms: hypotension, Conscious Sedation (mesh), Lidocaine (mesh), Clinical Trials and Supportive Activities (rcdc), Endoscopy (mesh), Propofol (mesh), Hypnotics and Sedatives (mesh), 11 Medical and Health Sciences (for), China (mesh), Aging (rcdc), Clinical Research (rcdc), Sufentanil (mesh), 42 Health sciences (for-2020), 80 and over (mesh), Cardiovascular System & Hematology (science-metrix), 32 Biomedical and Clinical Sciences (for-2020), Double-Blind Method (mesh), Male (mesh), 3202 Clinical Sciences (for-2020), Anesthetics, Aged, Humans (mesh), 6.1 Pharmaceuticals (hrcs-rac), Patient Safety (rcdc), propofol, Aged (mesh), Lidocaine, desaturation, Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), bidirectional endoscopy, 32 Biomedical and clinical sciences (for-2020), Female (mesh), Intravenous (mesh), Administration, Local (mesh)
File Description: application/pdf
-
14
Authors: et al.
Source: Trials. 25(1)
Subject Terms: 3214 Pharmacology and Pharmaceutical Sciences (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 42 Health Sciences (for-2020), Brain Disorders (rcdc), Behavioral and Social Science (rcdc), Clinical Research (rcdc), Methamphetamine (rcdc), Substance Misuse (rcdc), Clinical Trials and Supportive Activities (rcdc), Patient Safety (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Mental health (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Mirtazapine (mesh), Double-Blind Method (mesh), Amphetamine-Related Disorders (mesh), Methamphetamine (mesh), Adult (mesh), Middle Aged (mesh), Adolescent (mesh), Clinical Trials, Phase III as Topic (mesh), Male (mesh), Young Adult (mesh), Randomized Controlled Trials as Topic (mesh), Aged (mesh), Female (mesh), Treatment Outcome (mesh), Multicenter Studies as Topic (mesh), Australia (mesh), Time Factors (mesh), Medication Adherence (mesh), Antidepressive Agents, Tricyclic (mesh), Substance use disorders, Methamphetamine, Mirtazapine, Clinical trial, Depression, Sleep, Pharmacotherapy, Treatment, Psychiatry, Addiction, Humans (mesh), Amphetamine-Related Disorders (mesh), Methamphetamine (mesh), Antidepressive Agents, Tricyclic (mesh), Treatment Outcome (mesh), Double-Blind Method (mesh), Time Factors (mesh), Adolescent (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Australia (mesh), Female (mesh), Male (mesh), Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), Clinical Trials, Phase III as Topic (mesh), Medication Adherence (mesh), Young Adult (mesh), Mirtazapine (mesh), Addiction, Clinical trial, Depression, Methamphetamine, Mirtazapine, Pharmacotherapy, Psychiatry, Sleep, Substance use disorders, Treatment, Humans (mesh), Mirtazapine (mesh), Double-Blind Method (mesh), Amphetamine-Related Disorders (mesh), Methamphetamine (mesh), Adult (mesh), Middle Aged (mesh), Adolescent (mesh), Clinical Trials, Phase III as Topic (mesh), Male (mesh), Young Adult (mesh), Randomized Controlled Trials as Topic (mesh), Aged (mesh), Female (mesh), Treatment Outcome (mesh), Multicenter Studies as Topic (mesh), Australia (mesh), Time Factors (mesh), Medication Adherence (mesh), Antidepressive Agents, Tricyclic (mesh), 1102 Cardiorespiratory Medicine and Haematology (for), 1103 Clinical Sciences (for), Cardiovascular System & Hematology (science-metrix), General & Internal Medicine (science-metrix), 3202 Clinical sciences (for-2020), 4202 Epidemiology (for-2020), 4203 Health services and systems (for-2020)
File Description: application/pdf
-
15
Authors: et al.
Source: Orthopadie (Heidelb)
Die Orthopädie, 54(1):61-70Subject Terms: Funktionalität, Adults, Double-Blind Method [MeSH], Female [MeSH], Foot muscle exercises, Auflagefläche, Adult [MeSH], Foot function, Humans [MeSH], Prospective Studies [MeSH], Treatment Outcome [MeSH], Fußmuskeltraining, Fußdeformität, Middle Aged [MeSH], Foot contact area, Flatfoot/therapy [MeSH], Foot Orthoses [MeSH], Originalien, Male [MeSH], Erwachsene, Foot deformity
-
16
Authors: et al.
Source: Clin Drug Investig
Subject Terms: Male, Adult, Cross-Over Studies, Adolescent, Injections, Subcutaneous, Glucagon-Like Peptides, Middle Aged, Drug Administration Schedule, Young Adult, Drug Combinations, Insulin/administration, Adolescent [MeSH], Double-Blind Method [MeSH], Female [MeSH], Adult [MeSH], Drug Combinations [MeSH], Humans [MeSH], Hypoglycemic Agents/pharmacokinetics [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Drug Administration Schedule [MeSH], Middle Aged [MeSH], Diabetes Mellitus, Type 2/blood [MeSH], Insulin/pharmacokinetics [MeSH], Glucagon-Like Peptides/pharmacology [MeSH], Injections, Subcutaneous [MeSH], Male [MeSH], Cross-Over Studies [MeSH], Young Adult [MeSH], Glucagon-Like Peptides/administration, Original Research Article, Glucagon-Like Peptides/pharmacokinetics [MeSH], Hypoglycemic Agents/administration, Diabetes Mellitus, Type 2, Double-Blind Method, Humans, Hypoglycemic Agents, Insulin, Female
-
17
Authors: et al.
Source: Intensive Care Med
Subject Terms: Male, Cross Infection, Cross-Over Studies, Original, Pyridines, Bacteremia, Baths, Middle Aged, Intensive Care Units/statistics, Double-Blind Method [MeSH], Cross Infection/prevention, Aged [MeSH], Octenidine, Intensive care unit, Male [MeSH], Bacteremia/prevention, Anti-Infective Agents, Local/pharmacology [MeSH], Imines [MeSH], Baths/methods [MeSH], Female [MeSH], Pyridines/pharmacology [MeSH], Drug Resistance, Multiple, Bacterial/drug effects [MeSH], Pyridines/therapeutic use [MeSH], Antiseptic bathing, Humans [MeSH], Pyridines/administration, Middle Aged [MeSH], Anti-Infective Agents, Local/therapeutic use [MeSH], Cross-Over Studies [MeSH], Anti-Infective Agents, Local/administration, Germany [MeSH], Multidrug-resistant organisms, Intensive Care Units, Double-Blind Method, Drug Resistance, Multiple, Bacterial, Germany, Anti-Infective Agents, Local, Humans, Female, Imines, Aged
-
18
Authors: et al.
Source: Advances in Therapy. 40(11)
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Infectious Diseases (rcdc), Clinical Research (rcdc), Lung (rcdc), Emerging Infectious Diseases (rcdc), Coronaviruses (rcdc), Clinical Trials and Supportive Activities (rcdc), 6.1 Pharmaceuticals (hrcs-rac), 3 Good Health and Well Being (sdg), Humans (mesh), Female (mesh), Male (mesh), COVID-19 (mesh), Ramipril (mesh), SARS-CoV-2 (mesh), Retrospective Studies (mesh), Prospective Studies (mesh), Angiotensin-Converting Enzyme Inhibitors (mesh), Double-Blind Method (mesh), Treatment Outcome (mesh), COVID-19, Coronavirus, Ramipril, Therapy, Humans (mesh), Ramipril (mesh), Angiotensin-Converting Enzyme Inhibitors (mesh), Treatment Outcome (mesh), Retrospective Studies (mesh), Prospective Studies (mesh), Double-Blind Method (mesh), Female (mesh), Male (mesh), COVID-19 (mesh), SARS-CoV-2 (mesh), COVID-19, Coronavirus, Ramipril, Therapy, Humans (mesh), Female (mesh), Male (mesh), COVID-19 (mesh), Ramipril (mesh), SARS-CoV-2 (mesh), Retrospective Studies (mesh), Prospective Studies (mesh), Angiotensin-Converting Enzyme Inhibitors (mesh), Double-Blind Method (mesh), Treatment Outcome (mesh), 1115 Pharmacology and Pharmaceutical Sciences (for), General Clinical Medicine (science-metrix), 3202 Clinical sciences (for-2020), 3214 Pharmacology and pharmaceutical sciences (for-2020)
File Description: application/pdf
-
19
Authors: et al.
Source: BMJ Open. 13(11)
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Organ Transplantation (rcdc), Kidney Disease (rcdc), Transplantation (rcdc), Liver Disease (rcdc), Clinical Trials and Supportive Activities (rcdc), Cardiovascular (rcdc), Clinical Research (rcdc), Hypertension (rcdc), Digestive Diseases (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Oral and gastrointestinal (hrcs-hc), Adult (mesh), Humans (mesh), Angiotensin II (mesh), Liver Transplantation (mesh), End Stage Liver Disease (mesh), Severity of Illness Index (mesh), Living Donors (mesh), Vasoconstrictor Agents (mesh), Hypotension (mesh), Norepinephrine (mesh), Double-Blind Method (mesh), Catecholamines (mesh), Randomized Controlled Trials as Topic (mesh), Multicenter Studies as Topic (mesh), Angiotensin II, Liver Transplantation, Vasoconstrictor agents, End Stage Liver Disease, Liver Cirrhosis, Blood Pressure, Humans (mesh), Hypotension (mesh), Norepinephrine (mesh), Catecholamines (mesh), Angiotensin II (mesh), Vasoconstrictor Agents (mesh), Liver Transplantation (mesh), Severity of Illness Index (mesh), Double-Blind Method (mesh), Adult (mesh), Living Donors (mesh), Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), End Stage Liver Disease (mesh), Angiotensin II, Blood Pressure, End Stage Liver Disease, Liver Cirrhosis, Liver Transplantation, Vasoconstrictor agents, Adult (mesh), Humans (mesh), Angiotensin II (mesh), Liver Transplantation (mesh), End Stage Liver Disease (mesh), Severity of Illness Index (mesh), Living Donors (mesh), Vasoconstrictor Agents (mesh), Hypotension (mesh), Norepinephrine (mesh), Double-Blind Method (mesh), Catecholamines (mesh), Randomized Controlled Trials as Topic (mesh), Multicenter Studies as Topic (mesh), 1103 Clinical Sciences (for), 1117 Public Health and Health Services (for), 1199 Other Medical and Health Sciences (for), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020), 52 Psychology (for-2020)
File Description: application/pdf
-
20
Authors: et al.
Source: The New England Journal of Medicine. 389(11)
Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Liver Disease (rcdc), Hepatitis (rcdc), Digestive Diseases (rcdc), Clinical Research (rcdc), Clinical Trials and Supportive Activities (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Humans (mesh), Biopsy (mesh), Double-Blind Method (mesh), Fibroblast Growth Factors (mesh), Fibrosis (mesh), Gastrointestinal Agents (mesh), Injections, Subcutaneous (mesh), Non-alcoholic Fatty Liver Disease (mesh), Treatment Outcome (mesh), Humans (mesh), Fibrosis (mesh), Fibroblast Growth Factors (mesh), Gastrointestinal Agents (mesh), Biopsy (mesh), Treatment Outcome (mesh), Injections, Subcutaneous (mesh), Double-Blind Method (mesh), Non-alcoholic Fatty Liver Disease (mesh), Humans (mesh), Biopsy (mesh), Double-Blind Method (mesh), Fibroblast Growth Factors (mesh), Fibrosis (mesh), Gastrointestinal Agents (mesh), Injections, Subcutaneous (mesh), Non-alcoholic Fatty Liver Disease (mesh), Treatment Outcome (mesh), 11 Medical and Health Sciences (for), General & Internal Medicine (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)
File Description: application/pdf
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science